Foster James C's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Feb 17, 2023
- Accession no.
- 0001127602-23-005808
- Filed
- Feb 17, 2023
- Trade date
- Feb 15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foster James CCIK 0001141722 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Common Stock | SSaleDisposed | −19,892 | $250.00 | −$4,973,000 | 216,702 | Direct | |
| Feb 15, 2023 | Common Stock | SSaleDisposed | −108 | $250.16 | −$27,017.28 | 216,594 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.